Scientists propose in Nature blocking a molecule that drives inflammation and organ damage in Gaucher and maybe other lysosomal storage diseases as a possible treatment with fewer risks and lower costs than current therapies.
By redesigning the way it cares for children with active chronic conditions, Cincinnati Children’s successfully improved outcomes for 50 percent of more than 27,000 pediatric patients.
Genomic testing of biopsies from patients with deadly, treatment-resistant cancerous blood syndromes allowed doctors to identify genes fueling the ailments and use targeted molecular drugs to successfully treat them.
Cincinnati Children’s appoints John. J. McAuliffe III, MD, MBA, to the position of anesthesiologist-in-chief effective immediately.
Cincinnati Children’s researchers uncover long-term effects of traumatic brain injury (TBI) - an average of seven years after injury.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2017 Cincinnati Children's Hospital Medical Center. All rights reserved.